Literature DB >> 7603510

Clinical features of MELAS and mitochondrial DNA mutations.

Y Goto1.   

Abstract

MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes) is a distinct disorder characterized clinically by repeated strokelike attacks mostly beginning in childhood. We have paid special attention to the blood vessel abnormality seen in most biopsied muscle, in terms of the strokelike episodes in MELAS. The 3243 mutation in 80% of the typical MELAS patients has also been found in patients differing from the MELAS phenotype. Because we have examined muscle biopsies in 94 MELAS or 3243-positive patients, it is worthwhile to summarize the clinical and pathological findings and to prove the discrepancy between phenotype and genotype. This may be a starting point for further discussion of the pathomechanism and so toward further understanding of the disease itself.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7603510     DOI: 10.1002/mus.880181422

Source DB:  PubMed          Journal:  Muscle Nerve Suppl


  10 in total

1.  Humanin expression in skeletal muscles of patients with chronic progressive external ophthalmoplegia.

Authors:  Tesseki Kin; Kazuma Sugie; Makito Hirano; Yu-Ichi Goto; Ichizo Nishino; Satoshi Ueno
Journal:  J Hum Genet       Date:  2006-04-26       Impact factor: 3.172

Review 2.  The neuro-ophthalmology of mitochondrial disease.

Authors:  J Alexander Fraser; Valérie Biousse; Nancy J Newman
Journal:  Surv Ophthalmol       Date:  2010-05-14       Impact factor: 6.048

3.  Phenotype variability in 130 adult patients with respiratory chain disorders.

Authors:  J Finsterer; C Jarius; H Eichberger
Journal:  J Inherit Metab Dis       Date:  2001-10       Impact factor: 4.982

4.  Somatic alterations in mitochondrial DNA produce changes in cell growth and metabolism supporting a tumorigenic phenotype.

Authors:  Jana Jandova; Mingjian Shi; Kimberly G Norman; George P Stricklin; James E Sligh
Journal:  Biochim Biophys Acta       Date:  2011-11-15

5.  Isolated cytochrome c oxidase deficiency as a cause of MELAS.

Authors:  Walter Rossmanith; Michael Freilinger; Julia Roka; Thomas Raffelsberger; Karin Moser-Their; Daniela Prayer; Günther Bernert; Reginald Bittner
Journal:  BMJ Case Rep       Date:  2009-01-23

6.  Neuroradiological features of six kindreds with MELAS tRNA(Leu) A2343G point mutation: implications for pathogenesis.

Authors:  C M Sue; D S Crimmins; Y S Soo; R Pamphlett; C M Presgrave; N Kotsimbos; M J Jean-Francois; E Byrne; J G Morris
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

7.  Epidemiology and characteristics of occipital brain infarcts in young adults in southwestern Finland.

Authors:  Mika H Martikainen; Kari Majamaa
Journal:  J Neurol       Date:  2010-02       Impact factor: 4.849

Review 8.  Mitochondrial disease: mutations and mechanisms.

Authors:  Matthew McKenzie; Danae Liolitsa; Michael G Hanna
Journal:  Neurochem Res       Date:  2004-03       Impact factor: 3.996

Review 9.  Neuropathological aspects of mitochondrial DNA disease.

Authors:  Joanne Betts; Robert N Lightowlers; Douglass M Turnbull
Journal:  Neurochem Res       Date:  2004-03       Impact factor: 3.996

10.  Variable phenotypes in a family with mitochondrial encephalomyopathy harboring a 3291T > C mutation in mitochondrial DNA.

Authors:  Yoko Sunami; Keizo Sugaya; Norio Chihara; Yu-ichi Goto; Shiro Matsubara
Journal:  Neurol Sci       Date:  2011-08-24       Impact factor: 3.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.